Evidence map›Paper›PMID 35085231›Full record

ArticlePLoS biology2022

Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing.

Guadalupe J Jasso, Alok Jaiswal, Mukund Varma, Tyler Laszewski, Angelo Grauel, Abdifatah Omar, Nilsa Silva, Glenn Dranoff, Jeffrey A Porter, Keith Mansfield and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 95 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Targeted and quantitatively modeled biologic delivery via dual-functional probiotic yeast in inflammatory bowel disease.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. IL1βJournal of translational medicine · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Guadalupe J JassoBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Alok JaiswalBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-1910-4681
Mukund VarmaBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-9254-1247
Tyler LaszewskiNovartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.
Angelo GrauelNovartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.
Abdifatah OmarCenter for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0002-2682-8127
Nilsa SilvaNovartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.
Glenn DranoffNovartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.
Jeffrey A PorterNovartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.
Keith MansfieldNovartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.
Viviana CremascoNovartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.
Aviv RegevBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Ramnik J XavierBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-5630-5167
Daniel B GrahamBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Novartis (United States) · USBroad Institute · USMassachusetts General Hospital · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
RESEARCH TRAINING IN DIGESTIVE DISEASES AND NUTRITIONT32DK007191 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1986 to 2026
$14.6M
Systematic dissection of gut cellular circuits [at single cell resolution]RC2DK114784 · NIDDK · BROAD INSTITUTE, INC. · PI ASHENBERG, ORR, GRAHAM, DANIEL BARTHOLOMEW · 2017 to 2021
$9.0M
NIDDK NIH HHS P30 DK043351NIDDK NIH HHS RC2 DK114784NIDDK NIH HHS T32 DK007191
6 · The paper itself

Abstract

Chronic inflammation is often associated with the development of tissue fibrosis, but how mesenchymal cell responses dictate pathological fibrosis versus resolution and healing remains unclear. Defining stromal heterogeneity and identifying molecular circuits driving extracellular matrix deposition and remodeling stands to illuminate the relationship between inflammation, fibrosis, and healing. We performed single-cell RNA-sequencing of colon-derived stromal cells and identified distinct classes of fibroblasts with gene signatures that are differentially regulated by chronic inflammation, including IL-11-producing inflammatory fibroblasts. We further identify a transcriptional program associated with trans-differentiation of mucosa-associated fibroblasts and define a functional gene signature associated with matrix deposition and remodeling in the inflamed colon. Our analysis supports a critical role for the metalloprotease Adamdec1 at the interface between tissue remodeling and healing during colitis, demonstrating its requirement for colon epithelial integrity. These findings provide mechanistic insight into how inflammation perturbs stromal cell behaviors to drive fibroblastic responses controlling mucosal matrix remodeling and healing.

Indexed as

ADAM ProteinsAnimalsCell DifferentiationColitisColonExtracellular MatrixFibroblastsFibrosisGene Expression RegulationHumansInflammationInterleukin-11Intestinal MucosaMaleMesenchymal Stem CellsMiceAdamdec1 protein, mouseADAM ProteinsInterleukin-11Sodium Dodecyl Sulfate

Identifiers

PMID35085231
PMCPMC8824371
OpenAlexW4210410309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.